CRIS
CURIS INC
NASDAQ · Healthcare · Biotechnology · US
$0.40
+4.72%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 22.89x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.62x
- Price / sales
- 1.77x
- Price / cash flow
- -0.25x
Enterprise value
- Enterprise value
- $3.1M
- EV / sales
- 0.71x
- EV / EBITDA
- -0.14x
- EV / EBIT
- -0.09x
- Market cap
- $7.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026